News Column

CompanionDx Reference Lab and Enable Healthcare Inc. Announce Partnership to Deliver Pharmacogenomics Testing to Physician Practices

May 9, 2014



HOUSTON--(BUSINESS WIRE)-- CompanionDx Reference Lab, a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing, today announced that it has partnered with Enable Healthcare Incorporated (EHI), a leading Health Information Technology Solution and Services Provider. The strategic partnership provides EHI’s network of physician practices access to CompanionDx’s pharmacogenomics testing.

The CompanionDx and EHI partnership delivers a qualified and reliable pharmacogenomics laboratory partner to EHI’s physician practices. Results and reports from the testing will benefit the network of physicians in many ways including, recommendation on how to optimize patient therapy, assistance and aid in the approval of medications requiring prior authorizations (where medical necessity is demonstrated based on genetics), identification of poor and ultra-rapid metabolizers for optimizing future therapy to name a few.

“We are pleased to partner with EHI to make pharmacogenomics testing available to their physician network for improved patient outcomes,” said David Lasecki, President of CompanionDx. “The integrated system we utilize allows us to deliver testing results and reports directly to the Electronic Medical Records (EMR). The physician can then use this actionable information to optimize patient therapy and reduce adverse drug events.”

“Advanced capabilities in the field of pharmacogenomics and other rapidly growing areas leading to personalized medicine is the reason we chose CompanionDx as a partner,” stated Anthony Subbiah, Co-Founder and President of Enable Healthcare Inc. “We are excited about working with an intelligent, ethical and hardworking group of people who have the same passion and values as Team EHI. We are both focused on doing what is best for the patient, provider, payor and partners,” Subbiah added.

About CompanionDxTM

With locations in Houston, Texas and Honolulu, Hawaii, CompanionDx™ Reference Lab is a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing. CompanionDx™ is committed to the next evolution in cancer care where comprehensive genetic data is delivered in an actionable format, thereby enabling the physician to make treatment decisions and choose healthcare strategies based on unique cancer type and the genetic makeup of each patient. CompanionDx™’s comprehensive and tumor-specific panels, coupled with personalized pharmacogenomic analysis, provide a unique offering that allows physicians to choose relevant and targeted therapies. For more information, visit www.companiondxlab.com.

About Enable Healthcare Inc.

EHI is a Health Information Technology Solution and Services Provider serving the Ambulatory Care market with proprietary SaaS offerings adding value and benefits to Patients, Providers, Payors and Partners. Such product and service offerings include:

· Comprehensive Electronic Health Record Solutions

· Automated Practice Management Systems

· PCMH and ACO Management Solutions

· Interface and Connectivity (HISP) Solutions

· Patient/Personal Health Record Portal & Physician Portal

· Revenue Cycle Management Services and

· Health IT Integration Service

For more information, visit www.ehiconnect.com.




CompanionDx

David Lasecki, 330-687-0807

David.Lasecki@companiondxlab.com

Source: CompanionDx


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Business Wire


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters